|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
2
|
Calle EE and Thun MJ: Obesity and cancer.
Oncogene. 23:6365–6378. 2004. View Article : Google Scholar
|
|
3
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
|
|
4
|
Lorincz AM and Sukumar S: Molecular links
between obesity and breast cancer. Endocr Relat Cancer. 13:279–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Waard F, Baanders-Vanhalewijn EA and
Huizinga J: The bimodal age distribution of patients with mammary
carcinoma; evidence for the existence of 2 types of human breast
cancer. Cancer. 17:141–151. 1964.PubMed/NCBI
|
|
6
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosen ED and Spiegelman BM: Adipocytes as
regulators of energy balance and glucose homeostasis. Nature.
444:847–853. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kiess W, Petzold S, Topfer M, et al:
Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol
Metab. 22:135–153. 2008. View Article : Google Scholar
|
|
9
|
Clement K, Vaisse C, Lahlou N, et al: A
mutation in the human leptin receptor gene causes obesity and
pituitary dysfunction. Nature. 392:398–401. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buschemeyer WC III and Freedland SJ:
Obesity and prostate cancer: epidemiology and clinical
implications. Eur Urol. 52:331–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caldefie-Chezet F, Damez M, de Latour M,
et al: Leptin: a proliferative factor for breast cancer? Study on
human ductal carcinoma. Biochem Biophys Res Commun. 334:737–741.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rose DP, Komninou D and Stephenson GD:
Obesity, adipocytokines, and insulin resistance in breast cancer.
Obes Rev. 5:153–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laud K, Gourdou I, Pessemesse L, Peyrat JP
and Djiane J: Identification of leptin receptors in human breast
cancer: functional activity in the T47-D breast cancer cell line.
Mol Cell Endocrinol. 188:219–226. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garofalo C, Sisci D and Surmacz E: Leptin
interferes with the effects of the antiestrogen ICI 182,780 in
MCF-7 breast cancer cells. Clin Cancer Res. 10:6466–6475. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Catalano S, Mauro L, Marsico S, et al:
Leptin induces, via ERK1/ERK2 signal, functional activation of
estrogen receptor alpha in MCF-7 cells. J Biol Chem.
279:19908–19915. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frankenberry KA, Skinner H, Somasundar P,
McFadden DW and Vona-Davis LC: Leptin receptor expression and cell
signaling in breast cancer. Int J Oncol. 28:985–993.
2006.PubMed/NCBI
|
|
19
|
Saxena NK, Vertino PM, Anania FA and
Sharma D: Leptin-induced growth stimulation of breast cancer cells
involves recruitment of histone acetyltransferases and mediator
complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem.
282:13316–13325. 2007. View Article : Google Scholar
|
|
20
|
Catalano S, Marsico S, Giordano C, Mauro
L, Rizza P, Panno ML and Ando S: Leptin enhances, via AP-1,
expression of aromatase in the MCF-7 cell line. J Biol Chem.
278:28668–28676. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin N, Wang D, Zhang H, et al: Molecular
mechanisms involved in the growth stimulation of breast cancer
cells by leptin. Cancer Res. 64:5870–5875. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goodwin PJ, Ennis M, Fantus IG, Pritchard
KI, Trudeau ME, Koo J and Hood N: Is leptin a mediator of adverse
prognostic effects of obesity in breast cancer? J Clin Oncol.
23:6037–6042. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cirillo D, Rachiglio AM, la Montagna R,
Giordano A and Normanno N: Leptin signaling in breast cancer: an
overview. J Cell Biochem. 105:956–964. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen C, Chang YC, Liu CL, Chang KJ and Guo
IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is
associated with up-regulation of cyclin D1 and c-Myc and
down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast
Cancer Res Treat. 98:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garofalo C, Koda M, Cascio S, et al:
Increased expression of leptin and the leptin receptor as a marker
of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar
|
|
26
|
Thorn SR, Meyer MJ, Van Amburgh ME and
Boisclair YR: Effect of estrogen on leptin and expression of leptin
receptor transcripts in prepubertal dairy heifers. J Dairy Sci.
90:3742–3750. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ozet A, Arpaci F, Yilmaz MI, et al:
Effects of tamoxifen on the serum leptin level in patients with
breast cancer. Jpn J Clin Oncol. 31:424–427. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coe JE, Ishak KG, Ward JM and Ross MJ:
Tamoxifen prevents induction of hepatic neoplasia by zeranol, an
estrogenic food contaminant. Proc Natl Acad Sci USA. 89:1085–1089.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu S and Lin YC: Transformation of
MCF-10A human breast epithelial cells by zeranol and
estradiol-17beta. Breast J. 10:514–521. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takemura H, Shim JY, Sayama K, Tsubura A,
Zhu BT and Shimoi K: Characterization of the estrogenic activities
of zearalenone and zeranol in vivo and in vitro. J Steroid Biochem
Mol Biol. 103:170–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye W, Xu P, Threlfall WR, et al: Zeranol
enhances the proliferation of pre-adipocytes in beef heifers.
Anticancer Res. 29:5045–5052. 2009.PubMed/NCBI
|
|
32
|
Narro LA, Thomas MG, Silver GA, Rozeboom
KJ and Keisler DH: Body composition, leptin, and the leptin
receptor and their relationship to the growth hormone (GH) axis in
growing wethers treated with zeranol. Domest Anim Endocrinol.
24:243–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuri T, Tsukamoto R, Miki K, Uehara N,
Matsuoka Y and Tsubura A: Biphasic effects of zeranol on the growth
of estrogen receptor-positive human breast carcinoma cells. Oncol
Rep. 16:1307–1312. 2006.PubMed/NCBI
|
|
34
|
Liu S, Sugimoto Y, Sorio C, Tecchio C and
Lin YC: Function analysis of estrogenically regulated protein
tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell
line MCF-7. Oncogene. 23:1256–1262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gilbert NE, O’Reilly JE, Chang CJ, Lin YC
and Brueggemeier RW: Antiproliferative activity of gossypol and
gossypolone on human breast cancer cells. Life Sci. 57:61–67. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye W, Chang HL, Wang LS, et al: Modulation
of multidrug resistance gene expression in human breast cancer
cells by (-)-gossypol-enriched cottonseed oil. Anticancer Res.
27:107–116. 2007.PubMed/NCBI
|
|
37
|
Xu P, Ye W, Jen R, Lin SH, Kuo CT and Lin
YC: Mitogenic activity of zeranol in human breast cancer cells is
enhanced by leptin and suppressed by gossypol. Anticancer Res.
29:4621–4628. 2009.PubMed/NCBI
|
|
38
|
Lorincz AM and Sukumar S: Molecular links
between obesity and breast cancer. Endocr Relat Cancer. 13:279–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roy PG and Thompson AM: Cyclin D1 and
breast cancer. Breast. 15:718–727. 2006. View Article : Google Scholar : PubMed/NCBI
|
